**Core Concept:** Adult autologous stem cell transplant refers to the process of collecting, processing, and re-infusing the patient's own hematopoietic stem cells or immune cells to restore their hematopoietic system or immune function after high-dose chemotherapy or radiation therapy. This is a form of stem cell therapy used in the treatment of various malignant and non-malignant diseases.

**Why the Correct Answer is Right:**

Autologous stem cell transplant involves using the patient's own stem cells, which are collected, processed, and re-infused back into the patient after high-dose chemotherapy or radiation therapy to restore hematopoiesis (production of blood cells) and immune function. This process reduces the risk of immunological rejection and graft-versus-host disease (GVHD) commonly seen in allogeneic stem cell transplant.

**Why Each Wrong Option is Incorrect:**

A. Option A is incorrect because autologous stem cell transplant uses the patient's own stem cells, reducing the risk of immunological rejection and GVHD.
B. Option B is incorrect because, despite using the patient's own stem cells, autologous stem cell transplant still helps in restoring hematopoiesis and immune function.
C. Option C is incorrect because the process of collecting, processing, and re-infusing autologous stem cells still involves intervention and provides therapeutic benefits.
D. Option D is incorrect because the process of autologous stem cell transplant does not involve the use of a third-party stem cell source (allogeneic) nor does it eliminate the need for stem cell collection and processing.

**Clinical Pearl:**

Understanding the benefits and limitations of autologous stem cell transplant is crucial when choosing between autologous and allogeneic stem cell transplant options for patients undergoing hematopoietic malignancy treatment. Autologous stem cell transplant involves the use of the patient's own stem cells, reducing immunological rejection and GVHD risks, but still provides therapeutic benefits for hematopoietic recovery and immune system restoration.

In summary, the correct answer is D, as autologous stem cell transplant uses the patient's own stem cells, collects, processes, and re-infuses them to restore hematopoiesis and immune function. This option does not eliminate the need for stem cell collection and processing and does not involve using stem cells from a third-party source (allogeneic stem cell transplant).